| Imaging, biodistribution, and dosimetry of radionuclide-labeled PD-L1 antibody in an immunocompetent mouse model of breast cancer A Josefsson, JR Nedrow, S Park, SR Banerjee, A Rittenbach, F Jammes, ... Cancer research 76 (2), 472-479, 2016 | 169 | 2016 |
| (2S)-2-(3-(1-carboxy-5-(4-211At-astatobenzamido) pentyl) ureido)-pentanedioic acid for PSMA-targeted α-particle radiopharmaceutical therapy AP Kiess, IL Minn, G Vaidyanathan, RF Hobbs, A Josefsson, C Shen, ... Journal of Nuclear Medicine 57 (10), 1569-1575, 2016 | 137 | 2016 |
| Imaging of programmed death ligand-1 (PD-L1): impact of protein concentration on distribution of anti-PD-L1 SPECT agent in an immunocompetent melanoma murine model JR Nedrow, A Josefsson, S Park, S Ranka, S Roy, G Sgouros Journal of Nuclear Medicine, 58 (10), 1560-1566, 2017 | 83 | 2017 |
| Preclinical evaluation of 203/212Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer SR Banerjee, IL Minn, V Kumar, A Josefsson, A Lisok, M Brummet, J Chen, ... Journal of Nuclear Medicine 61 (1), 80-88, 2020 | 68 | 2020 |
| Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model JR Nedrow, A Josefsson, S Park, T Bäck, RF Hobbs, C Brayton, ... EJNMMI research 7, 1-16, 2017 | 45 | 2017 |
| Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting C Zhu, M Sempkowski, T Holleran, T Linz, T Bertalan, A Josefsson, ... Biomaterials 130, 67-75, 2017 | 42 | 2017 |
| Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer CJ Shen, I Minn, RF Hobbs, Y Chen, A Josefsson, M Brummet, ... Theranostics 10 (7), 2888-2896, 2020 | 40 | 2020 |
| Dosimetry and radiobiology of alpha-particle emitting radionuclides G Sgouros, R Hobbs, A Josefsson Current radiopharmaceuticals 11 (3), 209-214, 2018 | 26 | 2018 |
| Preclinical evaluation of 213Bi-and 225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer SR Banerjee, A Lisok, I Minn, A Josefsson, V Kumar, M Brummet, ... Journal of Nuclear Medicine 62 (7), 980-988, 2021 | 20 | 2021 |
| Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous … A Prasad, R Nair, O Bhatavdekar, A Howe, D Salerno, M Sempkowski, ... European journal of nuclear medicine and molecular imaging 48 (13), 4246-4258, 2021 | 18 | 2021 |
| Evaluation of [225Ac] Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma A Cortez, A Josefsson, G McCarty, AE Shtekler, A Rao, Z Austin, ... Nuclear Medicine and Biology 88, 62-72, 2020 | 18 | 2020 |
| Human HER2 overexpressing mouse breast cancer cell lines derived from MMTV. f. HuHER2 mice: characterization and use in a model of metastatic breast cancer S Park, JR Nedrow, A Josefsson, G Sgouros Oncotarget 8 (40), 68071, 2017 | 14 | 2017 |
| Comparative Dosimetry for 68Ga-DOTATATE: Impact of using Updated ICRP phantoms, S values and Tissue Weighting Factors. A Josefsson, RF Hobbs, S Ranka, BC Schwarz, D Plyku, CA Buchpiguel, ... Journal of Nuclear Medicine, 59 (8) 1281-1288, 2018 | 13 | 2018 |
| Microdosimetric analysis of 211At in thyroid models for man, rat and mouse A Josefsson, E Forssell-Aronsson EJNMMI research 2, 1-11, 2012 | 13 | 2012 |
| Evaluation of the Anisotropic Analytic Algorithm (AAA) for 6 MV photon energy A Josefsson M.Sc. Thesis, Göteborg University, Sahlgrenska Academy, Department of …, 2008 | 13 | 2008 |
| 68Ga-DOTATATE PET: temporal variation of maximum standardized uptake value in normal tissues and neuroendocrine tumours GB Coura-Filho, AAFO Hoff, PS Duarte, CA Buchpiguel, A Josefsson, ... Nuclear medicine communications 40 (9), 920-926, 2019 | 12 | 2019 |
| Re-evaluation of pediatric 18F-FDG dosimetry: Cristy-Eckerman versus UF/NCI hybrid computational phantoms K Khamwan, SE O’Reilly, D Plyku, A Goodkind, A Josefsson, X Cao, ... Physics in Medicine and Biology, 2018 | 11 | 2018 |
| Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered α-Particles May Realize the Promise for 225Ac in Large, Solid Tumors A Howe, O Bhatavdekar, D Salerno, A Josefsson, J Pacheco-Torres, ... Journal of Nuclear Medicine 63 (8), 1223-1230, 2022 | 10 | 2022 |
| Dosimetric analysis of 123I, 125I and 131I in thyroid follicle models A Josefsson, E Forssell-Aronsson EJNMMI research 4, 1-12, 2014 | 10 | 2014 |
| Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers D Salerno, A Howe, O Bhatavdekar, A Josefsson, J Pacheco‐Torres, ... Bioengineering & Translational Medicine 7 (2), e10266, 2022 | 8 | 2022 |
George SgourosProfessor of Radiology and Radiation Sciences, Johns Hopkins University在 jhmi.edu 的电子邮件经过验证
